PARG and ovarian cancer: Accordingly, hallmarks of replication catastrophe have been proposed as a biomarker, for instance, to predict the sensitivity to poly(ADP-ribose) glycohydrolase (PARG) inhibitors in subsets of ovarian cancer [197,198].